Abnormal Glucose Tolerance in Allogeneic Hematopoietic Stem Cell Transplantation

Not yet recruitingOBSERVATIONAL
Enrollment

1,000

Participants

Timeline

Start Date

November 30, 2024

Primary Completion Date

April 30, 2025

Study Completion Date

April 30, 2025

Conditions
ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATIONDiabetes MellitusImpaired Fasting Glucose
Trial Locations (6)

Unknown

The First Affiliated Hospital of Zhengzhou University, Zhengzhou

Tongji Hospital of Huazhong University of Science and Technology, Wuhan, Wuhan

Li Quan Hospital, Shanghai

Ruijin Hospital of Shanghai Jiaotong University, Shanghai

The First Hospital of Zhejiang University School of Medicine, Hangzhou

Hospital of Hematology of the Chinese Academy of Medical Sciences, Tianjin

All Listed Sponsors
lead

Ruijin Hospital

OTHER

NCT06704542 - Abnormal Glucose Tolerance in Allogeneic Hematopoietic Stem Cell Transplantation | Biotech Hunter | Biotech Hunter